Bill Snyder

Vanderbilt University biophysicist Gregor Neuert, Ph.D., M.Eng., is among 50 recipients of the 2014 National Institutes of Health (NIH) Director’s New Innovator Award. Each award provides up to $1.5 million in direct research support over five years. Read More

Michael Longaker, M.D., well known for his contributions to tissue repair and engineering and stem cell biology at Stanford University School of Medicine, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 16. Read More

A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223. Read More

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries. Read More

Jeff Balser, M.D., Ph.D., delivers Tuesday’s State of the Medical Center Address in Langford Auditorium. (photo by Joe Howell) He began with a simple thank you. That’s how Jeff Balser, M.D., Ph.D., Vanderbilt’s vice chancellor for Health Affairs and dean of the School of Medicine chose to… Read More

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee. Read More

Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses. Read More

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way. Read More

During presentations that were filled with messages about Vanderbilt University Medical Center’s purpose, addressing the “why” rather than detailing facts and figures, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, and C. Wright Pinson, MBA, M.D., deputy vice chancellor for Health Affairs and CEO of the Vanderbilt Health System, led the audience at Wednesday’s Fall Leadership Assembly through candid dialogue about VUMC’s way forward. Read More

Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection. Read More

Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder. Read More

Vanderbilt University welcomed 99 new doctoral students last Friday, Aug. 29, during the fifth annual “Simple Beginnings” ceremony in a Light Hall lecture room packed with family members and other well-wishers. Read More

Richard J. Smith, M.D., director of the Molecular Otolaryngology and Renal Research Laboratories (MORL) at the University of Iowa Carver College of Medicine, will begin the 2014-2015 Flexner Discovery Lecture Series on Thursday, Sept. 11. Read More

Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses? Read More

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis. Read More

It sounds like a potato chip. But CRISPR is actually the acronym for a new genome editing technique that, by many accounts, is accelerating the study of genes and disease. Read More

Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory. Read More

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders. Read More

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers. Read More

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies. Read More